For: | Yilmaz M, Celik U, Hascicek S. Radiation recall dermatitis with dabrafenib and trametinib: A case report. World J Clin Cases 2020; 8(3): 522-526 [PMID: 32110661 DOI: 10.12998/wjcc.v8.i3.522] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v8/i3/522.htm |
Number | Citing Articles |
1 |
Avik Mandal, Pritanjali Singh, Sarthak Tandon, Dharmendra Singh. “Radiation Recall Phenomenon” with Novel Cytotoxic Agents: An Emerging Trend in the Last Decade. Indian Journal of Medical and Paediatric Oncology 2021; 42(01): 028 doi: 10.1055/s-0041-1729729
|
2 |
Miroslav Důra. Skin toxicity of BRAF and MEK inhibitors. Onkologie 2021; 15(4): 169 doi: 10.36290/xon.2021.033
|
3 |
|
4 |
Elizabeth Guimond, Chiaojung Jillian Tsai, Ali Hosni, Grainne O'Kane, Jonathan Yang, Aisling Barry. Safety and Tolerability of Metastasis-Directed Radiation Therapy in the Era of Evolving Systemic, Immune, and Targeted Therapies. Advances in Radiation Oncology 2022; 7(6): 101022 doi: 10.1016/j.adro.2022.101022
|
5 |
Abhishek Purkayastha, Neelam Sharma, Sachin Taneja, Virender Suhag, Nishant Lohia. Sociodemographic, clinical profile, and treatment characteristics of oncology patients developing radiation recall phenomenon. Tzu Chi Medical Journal 2022; 34(3): 337 doi: 10.4103/tcmj.tcmj_163_21
|